Surgical Adhesive Skin Closure Supply (DERMABOND 2-Octyl Cyanoacrylate)

The contract is for the supply and delivery of FDA-approved DERMABOND 2-Octyl Cyanoacrylate surgical adhesive, provided in sealed unit containers that meet all federal medical standards and hazardous material handling regulations. The product must comply with MIL-STD-129 (MMS No. 1) labeling requirements to ensure proper identification, tracking, and logistics compatibility within military medical supply systems. This is a subcontract under the Medical Supply Chain MD Surg FSF, issued by the Department of Defense, targeting the Groton, Connecticut area as the designated place of performance. The NAICS code 325412 categorizes the procurement within pharmaceutical and medicinal product manufacturing, emphasizing the need for precision in formulation, sterility, and regulatory compliance. All deliveries must be fully aligned with DoD logistics frameworks to support seamless integration into military healthcare operations. Responses are due by July 27, 2026, with the solicitation posted on July 19, 2026, and must originate from vendors capable of meeting stringent quality, safety, and labeling mandates. The adhesive is intended for use in surgical skin closure applications, requiring consistent performance under operational field conditions. Vendors must demonstrate proven capacity to supply sealed, compliant units in required volumes, adhering to hazardous material transportation protocols and maintaining uninterrupted supply chain integrity. The absence of a set-aside designation indicates open competition among qualified subcontractors with appropriate certifications and experience in medical device manufacturing and defense logistics.